The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma
FEBS Open Bio · 2023-03 · 13 (3) · 545-555
DOI: 10.1002/2211-5463.13566 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, online erschienen am 12.02.2023. Verfasst von Victor S M C Correa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Retina Service, Ines and Fred Yeatts Retina Research Laboratory, Angiogenesis Laboratory, Department of Ophthalmology, Massachusetts Eye and Ear, Har…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Eye Institute, National Institutes of Health.
Abstract (Originalsprache)
Uveal melanoma (UM) is the most common primary intraocular cancer in the adult population. Recent studies suggested that the NLRP3 inflammasome could be a therapeutic target for cutaneous melanoma (CM), but the role of NLRP3 in UM remains unknown. Here, we analyzed the NLRP3‐IL‐1β axis in 5 UM and 4 CM cell lines. Expression of NLRP3 mRNA in UM and CM was low, and expression in UM was lower than in CM ( P < 0.001). NLRP3 protein levels were below detection limit for all cell lines. UM exhibited lower baseline IL‐1β secretion than CM, especially when compared to the Hs294t cell line ( P < 0.05). Bioinformatic analysis of human tumor samples showed that UM has significantly lower expression of NLRP3 and IL‐1β compared with CM. In conclusion, our work shows evidence of extremely low NLRP3 expression and IL‐1β secretion by melanoma cells and highlight differences between CM and UM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Retina Service, Ines and Fred Yeatts Retina Research Laboratory, Angiogenesis Laboratory, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Victor S M C Correa, Dimitrios P Ntentakis, Toshio Narimatsu
Förderung
- NEI NIH HHS
- National Eye Institute
- National Institutes of Health
- Research to Prevent Blindness
Zitieren
APA
Correa, V. S. M. C., Efstathiou, N. E., Ntentakis, D. P., Yu, Z., Narimatsu, T., Gragoudas, E., Kim, I. K., & Vavvas, D. G. (2023). The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma. FEBS Open Bio, 13(3), 545-555. https://doi.org/10.1002/2211-5463.13566
Vancouver
Correa VSMC, Efstathiou NE, Ntentakis DP, Yu Z, Narimatsu T, Gragoudas E, et al. The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma. FEBS Open Bio. 2023;13(3):545-555. doi:10.1002/2211-5463.13566
BibTeX
@article{Correa2023,
author = {Correa, Victor S M C and Efstathiou, Nikolaos E and Ntentakis, Dimitrios P and Yu, Zhen and Narimatsu, Toshio and Gragoudas, Evangelos and Kim, Ivana K and Vavvas, Demetrios G},
title = {The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma},
journal = {FEBS Open Bio},
year = {2023},
volume = {13},
number = {3},
pages = {545--555},
doi = {10.1002/2211-5463.13566}
}
EUVIMED